Thalidomide
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13607 publications
Corrigendum to "pH-driven butterfly effect for cascade-amplified tumor therapy based on thalidomide coordinated Fe-HMME nanoplatform" [Mater. Today Bio, 32 (2025) 101691].
Journal: Materials today. Bio
Published: June 22, 2026
Analysis of clinical and endoscopic characteristics of cap polyposis in children
Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: June 16, 2026
Recent advances in pathogenesis, diagnosis, and therapeutic strategies for POEMS syndrome
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: June 03, 2026
A Single Center Real-World Study of the Efficacy of Daratumumab-Based Regimens in the Treatment of Relapsed/Refractory Multiple Myeloma Patients
Journal: Zhongguo shi yan xue ye xue za zhi
Published: June 02, 2026
Single-center clinical study of upadacitinib in children with refractory inflammatory bowel disease
Journal: Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
Published: May 14, 2026
Treatment of Castleman disease from the perspective of the year 2026.
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: May 04, 2026
Discoid Lupus Erythematosus Successfully Treated With Anifrolumab.
Journal: Cureus
Published: May 03, 2026
Glycolic acid-integrated nanostructured lipid carriers of apremilast and quercetin co-delivery for the management of psoriasis.
Journal: Therapeutic delivery
Published: April 28, 2026
Targeted degradation of xanthine oxidase via PROTAC technology for the treatment of hyperuricaemia.
Journal: Journal of materials chemistry. B
Published: April 14, 2026
Patterns of care in relapsed/refractory multiple myeloma in China: a real-world physician survey study.
Journal: Future oncology (London, England)
Published: April 13, 2026
A new therapeutic approach for Parkinson's disease: dual targeting of α-Synuclein aggregation and microglial function by the novel immunomodulator 3-Monothiopomalidomide.
Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026
Last Updated: 06/30/2026